 |
|
|
| |
Sofosbuvir/Velpatasvir Is Safe and Effective in a Phase 3 Study of Genotype 1-3 HCV-infected Russian and Swedish Patients
|
| |
| |
Reported by Jules Levin
APASL 2018 March14-18 New Delhi
Vladamir Chulanov1, Ola Weiland2, Konstantin Zhdanov3, Brian McNabb4, Sophia Lu4, Evguenia S. Svarovskaia4, Robert H. Hyland4, Diana M. Brainard4, G. Mani Subramanian4, Dzhamal Abdurakhmanov5, Vasily Isakov6
1Clinical Diagnostics and Research Center, Central Research Institute of Epidemiology, Moscow, Russia; 2Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden; 3Military Medical Academy, St Petersburg, Russia; 4Gilead Sciences, Inc., Foster City, California, USA; 5Sechenov First Moscow State University, Moscow, Russia; 6Federal Research Center for Nutrition, Biotechnology and Food Safety, Moscow, Russia
|
| |
|
|
|
|
|
